The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Tumor Exosome Profiling Market Expected To Reach Based On Its 2026 Value?
The tumor exosome profiling market has undergone rapid expansion in recent years. Its valuation is anticipated to rise from $1.13 billion in 2025 to $1.32 billion by 2026, achieving a compound annual growth rate (CAGR) of 16.9%. This past growth can be ascribed to elements such as the increasing incidence of cancer, progress in molecular biology techniques, the rising embrace of liquid biopsy methods, increased research funding dedicated to oncology, and the imperative for non-invasive diagnostic instruments.
The tumor exosome profiling market is projected to experience substantial expansion in the coming years, reaching $2.49 billion by 2030, with a compound annual growth rate (CAGR) of 17.1%. This expansion during the forecast period is driven by factors such as the incorporation of AI and bioinformatics into exosome profiling, the creation of personalized medicine solutions, the increase in diagnostic laboratories, the embrace of advanced high-throughput exosome analysis platforms, and advances in cancer biomarker discovery. Key trends anticipated for this period involve the integration of liquid biopsy, high-throughput exosome analysis, automated sample preparation, multi-omics data profiling, and personalized cancer therapeutics.
Access Your Free Sample Report For In-Depth Market Analysis:
What Significant Factors Are Influencing The Tumor Exosome Profiling Market Expansion?
The rising occurrence of cancer is anticipated to drive the expansion of the tumor exosome profiling market moving forward. Cancer is defined as a collection of conditions marked by the unrestrained multiplication of aberrant cells that can invade surrounding tissues and metastasize to other body parts. This increasing prevalence of cancer stems from detrimental lifestyle choices such as inadequate nutrition, insufficient exercise, tobacco use, and excessive alcohol intake, all of which elevate the risk of developing various cancer types. Tumor exosome profiling assists in managing cancer by facilitating prompt diagnosis, tracking disease advancement, and informing tailored therapy approaches via examining tumor-derived exosomes present in bodily fluids. As an illustration, in February 2024, the World Health Organization, a Switzerland-based international organization specializing in global health policy and public health initiatives, projected over 35 million new cancer cases in 2050, representing a 77% increase from the estimated 20 million cases in 2022. Consequently, the increasing occurrence of cancer is a key factor boosting the swift development of the tumor exosome profiling market.
Which Segment Types Are Examined In The Tumor Exosome Profiling Market Segment Study?
The tumor exosome profiling market covered in this report is segmented –
1) By Product Type: Kits And Reagents, Instruments, Software, Services
2) By Sample Type: Blood, Urine, Saliva, Other Sample Types
3) By Application: Cancer Diagnostics, Prognostics, Therapeutics, Research
4) By End-User: Hospitals And Clinics, Research Institutes, Diagnostic Laboratories, Other End-Users
Subsegments:
1) By Kits And Reagents: Isolation Kits, Detection Kits, Quantification Kits, Labeling Reagents, Antibodies
2) By Instruments: Flow Cytometers, Nanoparticle Tracking Analyzers, Ultracentrifuges, Microfluidic Devices, Polymerase Chain Reaction Machines (PCR) Machines
3) By Software: Data Analysis Software, Visualization Software, Bioinformatics Platforms, Statistical Modeling Software, Exosome Tracking Software
4) By Services: Sample Preparation Services, Exosome Isolation Services, Molecular Profiling Services, Data Analysis Services, Custom Assay Development Services
Which Trends Are Impacting The Progress Of The Tumor Exosome Profiling Market?
Leading firms within the tumor exosome profiling market are prioritizing the creation of novel solutions, including liquid biopsy–based exosome assays, aimed at facilitating early cancer diagnosis and personalized treatment oversight. This type of assay involves a blood test capable of identifying minute vesicles, known as exosomes, which are shed by tumor cells, thereby enabling medical professionals to detect and track cancer without resorting to invasive tissue biopsies. As an illustration, in June 2024, Mercy BioAnalytics Inc., a US biotechnology firm, collaborated with University College London (UCL), a UK university, to introduce the Mercy Halo Ovarian Cancer Screening Test. This advanced extracellular vesicle liquid biopsy is engineered to detect ovarian cancer in postmenopausal women who show no symptoms, by identifying multiple co-localized cancer biomarkers on specific tumor-derived vesicles. It utilizes a small blood sample and a quantitative polymerase chain reaction (qPCR) based readout, delivering high sensitivity and specificity years prior to clinical diagnosis.
Which Players Are Part Of The Competitive Landscape Of The Tumor Exosome Profiling Market?
Major companies operating in the tumor exosome profiling market are Thermo Fisher Scientific Inc., Lonza Group Ltd., NanoFCM Inc., QIAGEN N.V., Bio-Techne Corporation, Miltenyi Biotec B.V. And Co. KG, Aethlon Medical Inc., Cusabio Technology LLC, Norgen Biotek Corp., Kimera Labs Inc, Diagenode Inc., Creative Biolabs Inc, Izon Science Ltd., System Biosciences LLC, Mercy Bioanalytics Inc, MtoZ Biolab, Capital Biosciences Inc., ExoCan Healthcare Technologies Private Limited, INOVIQ Ltd, Codiak BioSciences Inc.
Get The Full Tumor Exosome Profiling Market Report:
https://www.thebusinessresearchcompany.com/report/tumor-exosome-profiling-market-report
Which Region Leads The Tumor Exosome Profiling Market In Overall Market Size?
North America was the largest region in the tumor exosome profiling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor exosome profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Tumor Exosome Profiling Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Tumor Exosome Profiling Market 2026, By The Business Research Company
connected health personal medical devices market report 2026
contract sterilization market report 2026
https://www.thebusinessresearchcompany.com/report/contract-sterilization-global-market-report
orthotic insole 3-d printer market report 2026
https://www.thebusinessresearchcompany.com/report/orthotic-insole-3-d-printer-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model